The global Aptamers Market Growth Accelerated by Increased Adoption in Diagnostics and Therapeutics
Aptamers are single-stranded oligonucleotides typically made of DNA or RNA that undergo an in vitro selection process and act as ligands that bind to many targets with high affinity and specificity. They find widespread applications in diagnostics, research, and therapeutics. Aptamers offer advantages over antibodies such as easier production, low immunogenicity, better stability, and lower cost. The growing need for more affordable and effective diagnostics and therapeutics is driving the demand for aptamers. The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing R&D investments and clinical trials for aptamer-based therapeutic applications is one of the key trends fueling the growth of the aptamers market. Several biopharmaceutical companies are engaged in developing novel a...